CymitQuimica logo
Métabolisme

Métabolisme

Les inhibiteurs du métabolisme sont des composés qui interfèrent avec les voies métaboliques, modifiant ainsi la production et l'utilisation de l'énergie au sein des cellules. Ces inhibiteurs sont utilisés pour étudier la régulation du métabolisme, le rôle des voies métaboliques dans des maladies telles que le cancer et le diabète, et pour développer de nouvelles stratégies thérapeutiques. Les inhibiteurs du métabolisme peuvent cibler diverses enzymes et processus impliqués dans la glycolyse, l'oxydation des acides gras et d'autres fonctions métaboliques. Chez CymitQuimica, nous offrons une large gamme d'inhibiteurs de métabolisme de haute qualité pour soutenir vos recherches en biochimie, troubles métaboliques et développement de médicaments.

Sous-catégories appartenant à la catégorie "Métabolisme"

Affichez 34 plus de sous-catégories

9275 produits trouvés pour "Métabolisme"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • RMGPa-IN-1

    CAS :
    RMGPa-IN-1 (Compound 10C) is an inhibitor of rabbit muscle glycogen phosphorylase a (RMGPa), exhibiting an IC50 value of 82.5 μM. This compound holds potential for research in diabetes.
    Formule :C33H54O4
    Couleur et forme :Solid
    Masse moléculaire :514.779
  • Dihydrokainic acid

    CAS :
    EAAT2(GLT1)-selective non-transportable inhibitor of L-glutamate and L-aspartate uptake
    Formule :C10H17NO4
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :215.25
  • α-Glucosidase-IN-63

    CAS :
    α-Glucosidase-IN-63 (Compound 4d) serves as an α-Glucosidase inhibitor with an IC 50 value of 0.44 μM. Additionally, it exhibits inhibitory activity against hCA II, demonstrating a K i of 7.0 nM. The compound is also effective when administered orally. [1]
    Formule :C16H12FN3O3S2
    Couleur et forme :Solid
    Masse moléculaire :377.41
  • D-Citrulline

    CAS :
    D-Citrulline (H-D-Cit-OH), a stereoisomer of L-citrulline, effectively reduces cardiac contractile dysfunction caused by polymorphonuclear leukocyte (PMN) in isolated perfused rat hearts undergoing ischemia/reperfusion. This protective effect is mediated through a non-NO-mediated mechanism.
    Formule :C6H13N3O3
    Couleur et forme :Solid
    Masse moléculaire :175.19
  • Cephapirin lactone

    CAS :
    Cephapirinlactone is a metabolite of the antibiotic Cephapirin.
    Formule :C15H13N3O4S2
    Masse moléculaire :363.41
  • m-APTA

    CAS :
    m-APTA (5'-S-(3-aminophenyl)-5'-thioadenosine) is a selective chemoprotective agent targeting methylthioadenosine phosphorylase (MTAP). It can be converted into adenine, which is a crucial step in shielding normal cells from the toxicity of nucleobase analogs (NBA). m-APTA holds potential for research in MTAP-deficient cancers.
    Formule :C16H18N6O3S
    Couleur et forme :Solid
    Masse moléculaire :374.418
  • HSD17B13-IN-84

    CAS :
    HSD17B13-IN-84 (182) serves as an inhibitor of 17β-Hydroxysteroid dehydrogenases (HSD17B13), exhibiting an IC50 of less than 0.1 μM for Estradiol. It is primarily utilized in the study of NAFLD (Nonalcoholic fatty liver diseases) [1].
    Formule :C19H12Cl2F3N3O3S
    Masse moléculaire :490.28
  • MAFP

    CAS :
    MAFP (Methyl Arachidonyl Fluorophosphonate) is an effective irreversible inhibitor of anandamide amidase.
    Formule :C21H36FO2P
    Couleur et forme :Solid
    Masse moléculaire :370.48
  • hCA VB-IN-1


    hCA VB-IN-1 (compound 15) is a potent and selective inhibitor of hCA VB (carbonic anhydrase) with a KI of 515.7 nM [1].
    Formule :C9H13N3O4S
    Couleur et forme :Solid
    Masse moléculaire :259.28
  • HSD17B13-IN-32

    CAS :
    HSD17B13-IN-32 (Compound 67) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 value of ≤0.1 μM for estradiol. It can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH, as well as drug-induced liver injury (DILI) [1].
    Formule :C23H15Cl2N5O3
    Masse moléculaire :480.3
  • α-Glucosidase-IN-17

    CAS :
    α-Glucosidase-IN-17 (Compound 12B) is a potent and orally active inhibitor of α-glucosidase, demonstrating antidiabetic activity with an inhibitory
    Formule :C30H27NO2S
    Couleur et forme :Solid
    Masse moléculaire :465.61
  • hCAIX-IN-20

    CAS :
    hCAIX-IN-20 (compound APBS-5m) is a potent inhibitor of carbonic anhydrase IX (hCA IX), with a Ki of 2.7 nM, playing a significant role in cancer research.
    Formule :C19H13Cl2N5O4S2
    Masse moléculaire :510.37
  • Enpp-1-IN-7


    Enpp-1-IN-7: potent enpp-1 inhibitor, broad specificity, potential in cancer/infectious disease research. (WO2021203772A1)
    Formule :C18H19N7O4S
    Couleur et forme :Solid
    Masse moléculaire :429.45
  • PRL3-CNNM4 interaction-IN-1

    CAS :
    PRL3-CNNM4 interaction-IN-1 (Compound C28d52) is an inhibitor of the PRL3-CNNM4 interaction that also suppresses CNNM inhibition mediated by PRL. This compound exhibits favorable pharmacokinetic and drug metabolism properties.
    Formule :C8H8O2S
    Couleur et forme :Solid
    Masse moléculaire :168.21
  • HIF-1α-IN-5


    HIF-1α-IN-5 is an inhibitor of HIF-1α with an IC 50 value of 24 nM in HEK293T cells that also inhibits the activity of MAO-A.
    Formule :C16H15N3O2
    Couleur et forme :Solid
    Masse moléculaire :281.31
  • FTI-2148

    CAS :
    FTI-2148 blocks RAS-related FT-1 & GGT-1; IC50: 1.4 nM & 1.7 μM.
    Formule :C24H28N4O3S
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :452.57
  • HSD17B13-IN-19

    CAS :
    HSD17B13-IN-19 (compound 16) acts as a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting IC50 values under 0.1 μM and under 1 μM when using estradiol and Leukotriene B3 as substrates, respectively. This compound is crucial in the treatment of nonalcoholic fatty liver diseases (NAFLDs), such as nonalcoholic steatohepatitis (NASH) [1].
    Formule :C23H23FN2O4S
    Masse moléculaire :442.5
  • ABCB1-IN-4

    CAS :
    ABCB1-IN-4 (Compound C6z) is an orally active inhibitor of α-amylase and α-glucosidase, with IC50 values of 1.63 μM and 0.14 μM, respectively. It holds potential for diabetes research.
    Formule :C16H14N4S
    Couleur et forme :Solid
    Masse moléculaire :294.374
  • GT-02216

    CAS :
    GT-02216 is capable of binding allosterically to GCase, thereby enhancing its function. In primary human fibroblasts, it increases GCase activity and decreases Tau accumulation in mutant GBA1 fibroblasts. Additionally, GT-02216 offers protection to hippocampal primary neurons exposed to Tau oligomer in a rat model.
    Formule :C22H23N5O2
    Couleur et forme :Solid
    Masse moléculaire :389.45
  • TAK-828F

    CAS :
    TAK-828F: potent, selective RORγt inverse agonist. Oral. IC50=1.9 nM; reporter gene IC50=6.1 nM.
    Formule :C28H32FN3O5
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :509.57